Use of Artificial Intelligence Cardiac Ultrasound Technology in Teaching Point of Care Cardiac Ultrasound

NCT ID: NCT05297877

Last Updated: 2023-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-14

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate the effectiveness of artificial intelligence (A.I.) cardiac ultrasound technology in teaching point of care cardiac ultrasound (POCUS Cardiac).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

AI Machine

All study participants will undergo a full day (roughly 8 hours) training programme consisting of a pre-test MCQ, a didactic lecture, hands-on training session, a post-test MCQ, and a practical evaluation. They will be randomised to using an A.I. ultrasound machine for teaching.

Group Type EXPERIMENTAL

Experimental AI Echo Machine

Intervention Type OTHER

Participants will go through the training programme using an AI machine for learning.

Conventional Machine

All study participants will undergo a full day (roughly 8 hours) training programme consisting of a pre-test MCQ, a didactic lecture, hands-on training session, a post-test MCQ, and a practical evaluation. They will be randomised to using a conventional ultrasound machine for teaching.

Group Type OTHER

Conventional Echo Machine

Intervention Type OTHER

Participants will go through the training programme using a conventional machine for learning.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental AI Echo Machine

Participants will go through the training programme using an AI machine for learning.

Intervention Type OTHER

Conventional Echo Machine

Participants will go through the training programme using a conventional machine for learning.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical students with no prior training in point of care cardiac ultrasound

Exclusion Criteria

* Medical students who have received prior training in point of care cardiac ultrasound
* Participants who are unable to complete the entire training programme (pre-training MCQ, simulation session, post-training MCQ, practical evaluation, follow up practical evaluation one month later)
Minimum Eligible Age

19 Years

Maximum Eligible Age

30 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National University of Singapore

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NUS Anaesthesia

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suresh Paranjothy

Role: PRINCIPAL_INVESTIGATOR

National University Health System

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National University of Singapore

Singapore, , Singapore

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Singapore

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Suresh Paranjothy

Role: CONTACT

6772 6897

Vanessa Chua

Role: CONTACT

6772 6897

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Suresh Paranjothy

Role: primary

6772 6897

Vanessa Chua

Role: backup

6772 6897

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NUS-IRB-2021-484

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.